| Product Code: ETC6760544 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of carcinoembryonic antigen to Colombia in 2024 continued to be dominated by top exporting countries such as South Korea, China, Germany, the United Kingdom, and the United States of America. Despite a high Herfindahl-Hirschman Index indicating concentration, the industry experienced a negative compound annual growth rate of -6.0% from 2020 to 2024. Furthermore, there was a significant decline in growth rate from 2023 to 2024, with a decrease of -48.46%, highlighting potential challenges or shifts in the market dynamics during that period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Carcinoembryonic Antigen Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Carcinoembryonic Antigen Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Carcinoembryonic Antigen Market - Industry Life Cycle |
3.4 Colombia Carcinoembryonic Antigen Market - Porter's Five Forces |
3.5 Colombia Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Colombia Carcinoembryonic Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Colombia |
4.2.2 Growing awareness about early cancer detection and screening |
4.2.3 Technological advancements in diagnostic tests |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure in certain regions of Colombia |
4.3.2 High cost associated with diagnostic tests |
4.3.3 Regulatory challenges in the healthcare sector |
5 Colombia Carcinoembryonic Antigen Market Trends |
6 Colombia Carcinoembryonic Antigen Market, By Types |
6.1 Colombia Carcinoembryonic Antigen Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Colombia Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Colombia Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.4 Colombia Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.1.5 Colombia Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.6 Colombia Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.7 Colombia Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F |
6.1.8 Colombia Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2021- 2031F |
7 Colombia Carcinoembryonic Antigen Market Import-Export Trade Statistics |
7.1 Colombia Carcinoembryonic Antigen Market Export to Major Countries |
7.2 Colombia Carcinoembryonic Antigen Market Imports from Major Countries |
8 Colombia Carcinoembryonic Antigen Market Key Performance Indicators |
8.1 Adoption rate of carcinoembryonic antigen testing in Colombia |
8.2 Number of healthcare facilities offering carcinoembryonic antigen testing |
8.3 Research and development investments in new diagnostic technologies |
8.4 Patient survival rates post early detection of cancer |
8.5 Percentage of healthcare professionals trained in interpreting carcinoembryonic antigen test results |
9 Colombia Carcinoembryonic Antigen Market - Opportunity Assessment |
9.1 Colombia Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Colombia Carcinoembryonic Antigen Market - Competitive Landscape |
10.1 Colombia Carcinoembryonic Antigen Market Revenue Share, By Companies, 2024 |
10.2 Colombia Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |